Beyond Broken Links: The High Stakes of Provider Directory Accuracy in the No Surprises Era
Inaccuracies don’t just erode trust — they lead directly to surprise billing events, missed appointments,…
Beyond Broken Links: The High Stakes of Provider Directory Accuracy in the No Surprises Era
Inaccuracies don’t just erode trust — they lead directly to surprise billing events, missed appointments, care delays, and in some cases, enforcement action. The post Beyond Broken Links: The High Stakes of Provider Directory Accuracy in the No Surprises Era appeared first on MedCity News.
Journalists Assess Health Impacts of Trump’s Megabill, Who Will Feel Them, and When
KFF Health News chief Washington correspondent Julie Rovner discussed how cuts to Medicaid in President Donald Trump’s megabill will affect Americans’ access to health care on NPR’s “Up First,” CNN’s “CNN This Morning” and WNYC’s “The Brian Lehrer Show” on July 2. Rovner also discussed U.S. domestic and global vaccine policy on WAMU’s “1A” on July…
Friday Links
Trends in cost-related non-adherence.Optum Rx reduces reauthorization requirements.Changes in insulin out-of-pocket costs over time.AI and billable hours.Value in Health to include ‘Plan Language Summaries’
From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology
A systemic change from FFS to VBC would represent more than a payment model switch, but rather a holistic transition toward patient-centered healthcare that prioritizes outcomes over activity. The post From Fee-for-Service to Value-Based Care: Enhancing Outcomes in Nephrology appeared first on MedCity News.
With FDA Nod in Lung Cancer, Dizal Now Aims to Best a J&J Drug and Succeed Where Takeda Fell Short
Dizal Pharmaceutical’s Zegfrovy is now FDA approved for treating non-small cell lung cancer driven by a particular rare genetic signature. Johnson & Johnson drug Rybrevant already addresses this genetic signature as an earlier line of therapy, but Dizal executives contend their drug offers the potential for better safety and efficacy. The post With FDA Nod…
Eko Health’s AI for Cardiac Diagnoses Earns CMS Reimbursement Rate
This week, CMS established a reimbursement code for Eko Health’s AI platform, which seeks to aid clinicians in the diagnosis of heart conditions. The goal behind the technology is to help catch heart disease earlier, when it’s easier to treat, and to make high quality diagnostic care more accessible. The post Eko Health’s AI for…
States Brace for Reversal of Obamacare Coverage Gains Under Trump’s Budget Bill
Shorter enrollment periods. More paperwork. Higher premiums. The sweeping tax and spending bill pushed by President Donald Trump includes provisions that would not only reshape people’s experience with the Affordable Care Act but, according to some policy analysts, also sharply undermine the gains in health insurance coverage associated with it. The moves affect consumers and…
KFF Health News’ ‘What the Health?’: Trump’s Bill Reaches the Finish Line
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
What Administering My Father’s Home Infusions for 10 Years Taught Me About Improving Chronic Illness Care
It became clear to me that if my father’s life could be drastically improved with routine at-home care, so could many others. The next frontier in healthcare isn’t just about new medications or diagnostic tools; it’s about reimagining how and where we deploy our existing clinical expertise. The post What Administering My Father’s Home Infusions…
From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising
But where do truth and trust originate in healthcare marketing? They emerge from various sources such as digital advertising, educational campaigns, patient journeys, and partnerships with healthcare providers who uphold truth in advertising standards. The post From Magic Bullets to Medical Insights: How RFK Jr.’s Critique Shapes the Future of Pharma Advertising appeared first on…
